3 completed, 1 terminated, 1 unknown. 2 Phase 2, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow this drug Literature Review of Salicylates trials Research Report on Salicylates
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients Medicinal Plant, Salicylate, Vaseline - Keratosis Plantaris | Phase 2 | Completed | Universidade do Vale do Sapucai | 90 | 2017-06-01 | 2020-11-05 |
| Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne Trichloroacetic acid peel, combined azaleic and salicylic acids - Acne Vulgaris | Phase 3 | Completed | Cairo University | 34 | 2016-04-01 | 2017-03-07 |
| Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia Salsalate, Placebo - Anemia | Phase 2 | Terminated | Harvey Jay Cohen | 11 | 2012-03-01 | 2016-10-18 |
| 17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts 17% Salicylate with ethyl pyruvate, Salicylates - Warts | Phase 4 | Unknown | Grossman, Michael, D.P.M. | 100 | 2011-11-01 | 2012-10-23 |
| Using Salsalate to Target Adipocyte Macrophage Infiltration Salsalate (4 g/day), Placebo (4 g/day) - Diabetes Risk | Phase 1 | Completed | University of Southern California | 30 | 2011-07-01 | 2014-05-05 |
Acne Vulgaris (1) · Anemia (1) · Callosities (1) · Diabetes Mellitus (1) · Keratosis (1) · Obesity (1) · Warts (1)
Cairo University (1) · Grossman, Michael, D.P.M. (1) · Harvey Jay Cohen (1) · Universidade do Vale do Sapucai (1) · University of Southern California (1)
United States (3) · Brazil (1)
Jeremy Walston, MD (1) · Michael I Goran, PhD (1) · Michael R Grossman, DPM (1) · Stanley Schrier, MD (1) · Tanya L Alderete (1) · William Ershler, MD (1)
U01AG034661 (1)